Nabriva Therapeutics

-$0.0041 (-0.58%) As of 3:04 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBRV and other ETFs, options, and stocks.

About NBRV

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO.

CEO
Theodore R. Schroeder
Employees
72
Headquarters
Dublin, Dublin
Founded
2005

NBRV Key Statistics

Market cap
39.90M
Price-Earnings ratio
—
Dividend yield
—
Average volume
903.13K
High today
$0.7099
Low today
$0.70
Open price
$0.70
Volume
112.34K
52 Week high
$3.98
52 Week low
$0.6901

NBRV Earnings

-$2.60
-$1.73
-$0.87
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure